Universal Health Realty Income Trust

UHT remains entrenched in a Stage 4 decline, forming lower highs and lower lows beneath all key EMAs and the 200 SMA. Volume expands on down moves and rallies are consistently rejected at the 9/20 EMAs, confirming bearish structure and follow-through. Overbought context increases the risk of continued selling pressure, justifying immediate sell engagement. The primary risk is a support bounce at the 200 SMA that could temporarily stall downside execution.

• ↑Quarterly dividend of $0.71/share yields 1.35%, signaling stable cash flows
• ↑Q2 2026 share repurchases totaled $320M, reflecting undervaluation belief
• ↓Negative growth and profitability indicators suggest revenue conversion challenges